Clinical Trials
441
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (331 trials with phase data)• Click on a phase to view related trials
Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy
- Conditions
- Gastric Cancer
- First Posted Date
- 2025-07-09
- Last Posted Date
- 2025-07-09
- Target Recruit Count
- 30
- Registration Number
- NCT07056010
- Locations
- 🇨🇳
First Affiliated Hospital of Nanjing Medical Unviersity, Nanjing, Jiangsu, China
A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen Concentration Embryo Culture Protocols in Assisted Reproductive Technology
- Conditions
- Blastocyst IVFFertility IssuesEmbryo Culture
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Target Recruit Count
- 980
- Registration Number
- NCT07050537
- Locations
- 🇨🇳
The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
🇨🇳Changzhou Maternal And Child Health Care Hospital, Changzhou, Jiangsu, China
🇨🇳Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, China
Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial
- Conditions
- Gastric Cancer Stage III
- Interventions
- Dietary Supplement: Omega-3 SupplementationDrug: Neoadjuvant Immunotherapy
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Target Recruit Count
- 80
- Registration Number
- NCT07050524
- Locations
- 🇨🇳
First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China
The Risk Factors Related to Rupture Flow-related Aneurysms in Posterior AVM
- Conditions
- Arteriovenous Malformation of Central Nervous SystemAneurysm, RupturedAneurysm CerebralAneurysmatic Subarachnoid Haemorrhage
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Target Recruit Count
- 200
- Registration Number
- NCT07050381
- Locations
- 🇨🇳
Jiangsu Province Hospital, Nanjing, Jiangsu, China
🇨🇳the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing
- Conditions
- Non Muscle Invasive Bladder Cancer
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Target Recruit Count
- 428
- Registration Number
- NCT07036731
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, Nanjing, Jiangsu, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 88
- Next